Stocktoria

Semnur Pharmaceuticals, Inc. SMNR

OTC · stock · Pharmaceutical Preparations · IPO 2022-04-07

Semnur Pharmaceuticals, Inc. statistics & valuation

Market cap$230.2M

Market cap as of 2026-06-30. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
2022202320242025
Operating margin (%)
2022202320242025
Return on equity (%)
2022202320242025
Shares outstanding
200.0M 230.2M 2022202320242025
Net debt ($)
2022202320242025
Share buybacks ($)
2022202320242025
Return on assets (%)
-0.50% 1.20% -70.20% -11918.00% 2022202320242025
Free cash flow margin (%)
2022202320242025
Debt / equity (×)
2022202320242025
EPS ($)
-$0.02 -$0.78 2022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022
Return on assets-11918.0%-70.2%1.2%-0.5%
Return on equity773.1%11.0%-1.7%12.8%
Current ratio0.06171.290.040.70

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.